Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study

Neuroscience Letters

Volumn 204, Issue 3, 1996, Pages 177-180

  Helkala, E L ^a,c   Koivisto, K ^a   Hanninen T ^a   Vanhanen, M ^a   Kervinen, K ^b   Kuusisto, J ^a   Mykkanen L ^a   Kesaniemi Y A ^b   Laakso, M ^a   Riekkinen Sr , P ^c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Aging; Apolipoprotein E phenotypes; Memory

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGY; PRIORITY JOURNAL;

EID: 17144451033     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12348-X     Document Type: Article

References (21)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. (DSM-III). In Task Force on Nomenclature and Statistics, American Psychiatric Association, Washington, D.C., 1980.
2. Borkowski, J.G., Benton, A.L. and Spreen, O., Word fluency and brain damage, Neuropsychologia, 5 (1967) 135-140.
3. Buschke, H. and Fuld, P.S., Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology, 24 (1974) 1019-1025.
4. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, O.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
5. Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E. and Uterman, G., Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentration, J. Lipid Res., 27 (1986) 227-235.
6. Eichner, J.E., Kuller, L.H., Orchard, T.J., Grandits, G.A., McCallum, L.M., Ferrell, R.E. and Neaton, J.D., Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease, Am. J. Cardiol., 71 (1993) 160-165.
7. Folstein, M.F., Folstein, S.E. and McHugh, P.R., 'Mini-Mental state': a practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12 (1975) 189-198.
8. Helkala, E.-L., Koivisto, K., Hänninen, T., Vanhanen, M., Kervinen, K., Kuusisto, J., Mykkänen, L., Kesäniemi, A., Laakso, M. and Riekkinen, P., The association of apolipoprotein E polymorphism with cognitive performance: population based study, Neurosci. Lett., 191 (1995) 141-144.
9. Hultsch, D.F., Hertzog, C., Small, B.J., McDonald-Miszczak, L. and Dixon, R., Short-term longitudinal change in cognitive performance in later life, Psychol. Aging, 7 (1992) 571-584.
10. Kervinen, K., Savolainen, M.J., Salokannel, J., Hynninen, A., Heikkinen, J., Ehnholm, C., Koistinen M.J. and Kesäniemi, Y.A., Apolipoprotein E and B polymorphism: longevity factors assessed in nonagenarians, Atherosclerosis, 105 (1994) 89-95.
11. Kuusisto, J., Koivisto, K., Kervinen, K., Mykkänen, L., Helkala, E.-L., Vanhanen, M., Hänninen, T., Pyörälä, K., Kesäniemi, Y.A., Riekkinen, P. and Laakso, M., Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study, Br. Med. J., 309 (1994) 636-638.
12. Kuusisto, J., Mykkänen, L., Kervinen, K., Kesäniemi, A. and Laakso, M., Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects, Arteriorscler. Thromb. Vase. Biol., 15 (1995) 1280-1286.
13. Louhija, J., Miettinen, H.E., Kontula, K., Tikkanen, M.J., Miettinen, T.A. and Tilvis, R.S., Aging and genetic variation of plasma apolipoproteins: relative loss of the apolipoprotein ε4 phenotype in centenarians, Arterioscler. Thromb., 14 (1994) 1084-1089.
14. Mykkänen, L., Laakso, M., Uusitupa, M. and Pyörälä K., Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes, Diabetes Care, 13 (1990) 1099-1105.
15. Reed, T., Carmelli, D., Swan, G.E., Breitner, J.C.S., Welsh, K.A., Jarvik, G.P., Deeb, S. and Auwerx, M.D., Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele, Arch. Neurol., 51 (1994) 1189-1192.
16. Reitan, R.M., Validity of the Trail Making test as an indicator of organic brain damage, Percept. Mot. Skills, 8 (1958) 271-276.
17. Rowe, J.W. and Kahn, R.L., Human aging: usual and successful, Science, 237 (1987) 143-149.
18. Russel, E.W., A multiple scoring method for the assessment of complex memory functions, J. Consult. Clin. Psychol., 43 (1975) 800-809.
19. Stam, F.C., Wigboldus, J.M. and Smeudler, W.M., Age incidence of senile brain amyloidosis, Pathol. Res. Pract., 181 (1986) 558-562.
20. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M.A., Enghild, J., Salvesen, G.S. and Roses A.D., Apolipoprotein-E: high avidity binding to β-amyloid and increased frequency of type-4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 1977-1981.
21. Talbot, C.E., Lendon, C., Craddock, N., Shears, S., Morris, J.C. and Goate, A., Protection against Alzheimer's disease with apoE ε2, Lancet, 343 (1994) 1432-1433.